Highly sensitive Lens culinaris agglutinin-reactive α-fetoprotein: a new tool for the management of hepatocellular carcinoma
- PMID: 22212938
- DOI: 10.1159/000333263
Highly sensitive Lens culinaris agglutinin-reactive α-fetoprotein: a new tool for the management of hepatocellular carcinoma
Abstract
Objectives: The highly sensitive Lens culinaris agglutinin-reactive α-fetoprotein (hs-AFP-L3), measured using a newly developed method involving microfluidics-based separation technology, was evaluated as a new tool for the management of hepatocellular carcinoma (HCC) in clinical practice.
Methods: The sensitivity and specificity of hs-AFP-L3 for the diagnosis of HCC and its ability to predict the outcome of patients with HCC were analyzed based on reported studies.
Results: Compared to AFP-L3 measured using conventional methods, the sensitivity of hs-AFP-L3 was markedly higher and the specificity was comparable. In all studies, multivariate analysis found that elevation of hs-AFP-L3 was an independent factor that affected patient survival.
Conclusions: The use of hs-AFP-L3 improves the true positive rate of patients with HCC at diagnosis, maintaining the high specificity of AFP-L3 and its indicative value for poor prognosis. The utility of this tumor marker for prediction of the development of HCC in high-risk patients under surveillance needs to be investigated.
Copyright © 2011 S. Karger AG, Basel.
Similar articles
-
Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein <20 ng/mL.Cancer Sci. 2011 May;102(5):1025-31. doi: 10.1111/j.1349-7006.2011.01875.x. Epub 2011 Feb 28. Cancer Sci. 2011. PMID: 21244578
-
Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease.Oncol Rep. 2011 Nov;26(5):1227-33. doi: 10.3892/or.2011.1425. Epub 2011 Aug 19. Oncol Rep. 2011. PMID: 21874252
-
Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma.Liver Int. 2005 Aug;25(4):848-53. doi: 10.1111/j.1478-3231.2005.01111.x. Liver Int. 2005. PMID: 15998436
-
[Tumor markers for hepatocellular carcinoma].Nihon Rinsho. 2012 May;70(5):821-7. Nihon Rinsho. 2012. PMID: 22620007 Review. Japanese.
-
Serological markers of liver cancer.Best Pract Res Clin Gastroenterol. 2005 Feb;19(1):91-9. doi: 10.1016/j.bpg.2004.10.003. Best Pract Res Clin Gastroenterol. 2005. PMID: 15757806 Review.
Cited by
-
Serum protein biomarkers for HCC risk prediction in HIV/HBV co-infected people: a clinical proteomic study using mass spectrometry.Front Immunol. 2023 Nov 10;14:1282469. doi: 10.3389/fimmu.2023.1282469. eCollection 2023. Front Immunol. 2023. PMID: 38022651 Free PMC article.
-
HIV-HBV Coinfection-Current Challenges for Virologic Monitoring.Biomedicines. 2023 Apr 28;11(5):1306. doi: 10.3390/biomedicines11051306. Biomedicines. 2023. PMID: 37238976 Free PMC article. Review.
-
Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.World J Gastroenterol. 2013 Jan 21;19(3):339-46. doi: 10.3748/wjg.v19.i3.339. World J Gastroenterol. 2013. PMID: 23372355 Free PMC article.
-
Novel biomarkers for the management of chronic hepatitis B.Clin Mol Hepatol. 2020 Jul;26(3):261-279. doi: 10.3350/cmh.2020.0032. Epub 2020 Jun 15. Clin Mol Hepatol. 2020. PMID: 32536045 Free PMC article. Review.
-
Enzymes for N-Glycan Branching and Their Genetic and Nongenetic Regulation in Cancer.Biomolecules. 2016 Apr 28;6(2):25. doi: 10.3390/biom6020025. Biomolecules. 2016. PMID: 27136596 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical